Evidence map›Paper›PMID 41703122›Full record

ArticleScientific reports2026

Characterization of conserved residues in the mammarenavirus matrix protein Z using novel Lassa virus life cycle modelling assays.

Claudia Bastl, Barbara Posch, Madita Kudla, Juliette Dupré, Marine Noël Klamke, Anne Leske, Kyle Warren Shifflett, Cedric Rajes, Allison Groseth, Thomas Hoenen and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Claudia Bastl *Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, Greifswald - Insel Riems, Riems, Germany.
Barbara Posch *Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, Greifswald - Insel Riems, Riems, Germany.
Madita KudlaInstitute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, Greifswald - Insel Riems, Riems, Germany.
Juliette DupréInstitute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, Greifswald - Insel Riems, Riems, Germany.
Marine Noël KlamkeInstitute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, Greifswald - Insel Riems, Riems, Germany.
Anne LeskeInstitute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, Greifswald - Insel Riems, Riems, Germany.
Kyle Warren ShifflettLaboratory of Virology, Division of Intramural Research, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA.
Cedric RajesInstitute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, Greifswald - Insel Riems, Riems, Germany.
Allison GrosethInstitute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, Greifswald - Insel Riems, Riems, Germany.
Thomas HoenenInstitute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, Greifswald - Insel Riems, Riems, Germany. thomas.hoenen@fli.de.
Lisa WendtInstitute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, Greifswald - Insel Riems, Riems, Germany. lisa.wendt@med.uni-heidelberg.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lassa virus (LASV) is the causative agent of Lassa fever, which causes thousands of deaths every year within the endemic regions of West Africa. Despite its discovery over half a century ago, our knowledge regarding basic steps in the LASV life cycle remains limited. In order to simplify studying basic principles of the LASV life cycle, we developed a novel transcription- and replication-competent virus-like particle (trVLP) system that can model the whole virus life cycle using only authentic LASV components but without the need for a maximum containment laboratory. As a proof-of-concept we used this system, together with classical minigenome systems, to determine the functional contributions of highly conserved amino acids within the mammarenavirus matrix protein Z. We could demonstrate that residues L71 and P72 are essential for the role of Z in inhibiting viral RNA synthesis, with residues R16, D22, K68 and T73 also contributing to this function. Additionally, we showed that L71-T73 mediate interaction of Z with the viral nucleoprotein (NP), which is also supported by residue G2. Given the critical role of these interactions in the virus life cycle, understanding these amino acids’ functions will help to define potential targets for the development of urgently needed countermeasures.

Indexed as

Lassa virusViral Matrix ProteinsAfrica, WesternAmino Acid SequenceAnimalsCell Line, TumorChlorocebus aethiopsConserved SequenceHumansLassa FeverLife Cycle StagesNucleoproteinsRNA, ViralVirus ReplicationNucleoproteinsRNA, ViralViral Matrix Proteins

Identifiers

PMID41703122
PMCPMC13005004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.